Form 4: Teladoc Health CEO Jason Gorevic Acquires Restricted Stock Units

Teladoc Health's CEO, Jason Gorevic, acquired 197,728 restricted stock units on March 19, 2024, according to a recent SEC filing.

Summary

• Jason Gorevic, the CEO of Teladoc Health, acquired 197,728 restricted stock units on March 19, 2024.
• These restricted stock units represent a contingent right to receive one share of Teladoc Health common stock each.
• The vesting schedule for these units is as follows: one-third vests on the first anniversary of the grant date, and the remaining units vest in eight substantially equal quarterly installments starting on June 1, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CEO's acquisition of restricted stock units suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of restricted stock units by the CEO aligns his interests with those of the shareholders, as the value of the units is tied to the performance of the company's stock.

Future Outlook

The vesting schedule suggests a long-term commitment by the CEO to the company's success.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's confidence in the company's prospects. This transaction indicates the CEO's belief in Teladoc's future performance.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it aligns the CEO's interests with theirs.

Key Dates